Zinzino AB (publ.)

    213 Aufrufe 213 0 Kommentare 0 Kommentare

    Preliminary Sales Report Q3 2025

    Zinzino group revenue increased 48% in Q3, compared with the previous year.

    GOTHENBURG, Sweden, Oct. 3, 2025 /PRNewswire/ -- The revenue in September 2025 for Zinzino's sales markets increased by 53 % and amounted to SEK 273.5 (178.7) million. Faun Pharma's external sales decreased and amounted to SEK 3.7 (5.8) million. Overall, the Group increased revenues by 50% to SEK 277.2 (184..5) million compared with the previous year.

    Revenue in Zinzino's sales markets increased by 54 % in the third quarter of 2025 compared with the same period last year and amounted to SEK 777.3 (504.4) million. Total revenues in the Group increased by 48% in the third quarter and amounted to SEK 786.7 (532.8) million.

    Accumulated revenue for January – September 2025 increased by 54% to SEK 2,304.9 (1,494.3) million.

    Revenues were distributed as follows:
     

    Regions, mSEK

    25-Sep

    24-Sep

    Change

    Q3 2025

    Q3 2024

    Change

    YTD 2025

    YTD 2024

    Change

    The Nordics

    26.5

    25.4

    4 %

    79.6

    72.5

    10 %

    235.1

    214.0

    10 %

    Central Europe

    93.8

    48.7

    93 %

    242.8

    138.6

    75 %

    657.9

    394.4

    67 %

    East Europe

    29.4

    28.3

    4 %

    89.7

    88.3

    2 %

    276.2

    279.9

    -1 %

    South & West Europe

    50.1

    38.0

    32 %

    137.2

    104.2

    32 %

    399.2

    264.5

    51 %

    The Baltics

    8.9

    7.2

    24 %

    28.6

    21.9

    31 %

    85.3

    69.4

    23 %

    North America

    41.3

    20.3

    103 %

    129.8

    52.6

    147 %

    382.1

    134.0

    185 %

    Asia-Pacific

    21.6

    9.6

    125 %

    63.7

    22.3

    186 %

    212.7

    47.5

    348 %

    Africa

    1.9

    1.2

    58 %

    5.8

    4.0

    46 %

    16.0

    10.9

    47 %

    Zinzino

    273.5

    178.7

    53 %

    777.3

    504.4

    54 %

    2264.5

    1414.6

    60 %

    Faun Pharma

    3.7

    5.8

    -36 %

    9.4

    28.4

    -67 %

    40.4

    79.7

    -49 %

    Zinzino Group

    277.2

    184.5

    50 %

    786.7

    532.8

    48 %

    2304.9

    1494.3

    54 %

    Countries in regions:

    -The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

    -Central Europe: Austria, Germany, Switzerland

    -East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

    -South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

    -The Baltics: Estonia, Latvia, Lithuania

    -North America: Canada, USA, Mexico

    -Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines

    -Africa: South Africa

    For more information:
    Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com

    Pictures for publication free of charge: marketing@zinzino.com

    Certified Adviser: DNB Carnegie Investment Bank AB (publ.)

    This information was brought to you by Cision http://news.cision.com

    https://news.cision.com/zinzino/r/zinzino-ab--publ--preliminary-sales-report-q3-2025,c4245047

    The following files are available for download:

    https://mb.cision.com/Public/10976/4245047/8318f1070684a5d1.pdf

    Pressrelease-sales-report-2025-09-en

     

    Cision View original content:https://www.prnewswire.co.uk/news-releases/zinzino-ab-publ-preliminary-sales-report-q3-2025-302574616.html





    PR Newswire (engl.)
    0 Follower
    Autor folgen

    Verfasst von PR Newswire (engl.)
    Zinzino AB (publ.) Preliminary Sales Report Q3 2025 Zinzino group revenue increased 48% in Q3, compared with the previous year. GOTHENBURG, Sweden, Oct. 3, 2025 /PRNewswire/ - The revenue in September 2025 for Zinzino's sales markets increased by 53 % and amounted to SEK 273.5 (178.7) million. Faun …